NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » Articles posted by venugopalimmadi

All articles by Venugopal immadi

Best practice: solid risk management plan

|Sini Eskola has been director of regulatory affairs at the European Federation of Pharmaceutical Industries and Associations (EFPIA) sinceFebruary 2014. Prior to joining EFPIA, she worked at AstraZeneca’s R&D|Risk management is necessary in clinical trials to protect patients.|A good RMP should maximise patient safety without stymieing drug development.

A penny saved: clinical supplies funding

|Didier Basseras has been vice-president of clinical supplies at Sanofi R&D since 2009. At Sanofi, he leads the full integration of clinical supply chain through acquisitions, mergers and terminations. He is a trained pharmacist and a graduate of the European Institute of Pharmaceutical Industry.|Tighter regulation on patient safety, and the development of new and expensive treatments have driven up costs of clinical trials.|There is significant demand for affordable treatments for chronic conditions.